(Date:11/23/2009)..., Mass. November 23, 2009 Applied mathematicians...osta lancifolia ), a characteristic long leaf with...ipples along the edges. The simple cause of the li...om bending during differential growthwas revealed ...oam ribbons. , Haiyi Liang, a postdoctoral stude...
(Date:11/23/2009).... -- More than 160 participants gathered this week...TURES INITIATIVE conference. This year,s topic, "S...gineers, and medical researchers to explore the en...ng the emerging field of synthetic biology. , Bo... Princeton University and this year,s conference c...
(Date:11/23/2009)...- The only swine vaccine available for the H1N1 vi...ed with the virus. The vaccination marks the first...sed with the pandemic flu., Iowa State Universit...loped the vaccine this summer and has been shippin...sas and Illinois for several weeks., The latest ...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Iowa State researcher produces, ships only H1N1 vaccine available for swine 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 1Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 2Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems 14261 3Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 1Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 2Bionovo to Present on Novel Female Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society 14259 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 1DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 2DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 3DOR BioPharma Announces Private Equity Financing of 243 85 Million with its Partner Sigma Tau and Other Institutional Investors 5060 4